• Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment

  • Feb 6 2025
  • Length: 5 mins
  • Podcast

Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment

Listen for free

View show details

  • Summary

  • In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the pros and cons of virtual neurology education, the FDA approval of tirzepatide for obesity-related obstructive sleep apnea, and the promise of AI for glioma assessment.

    Show more Show less
Show more Show less

What listeners say about Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available